Literature DB >> 29366734

Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.

Jingchuan Guo1, Rachel G Miller1, Tina Costacou1, William P Follansbee2, Trevor J Orchard3.   

Abstract

OBJECTIVES: We aimed to assess association between abnormal LVEF, in the absence of coronary artery disease (CAD), and 25-year incidence of major outcomes of diabetes (MOD) in a cardiology substudy of the Pittsburgh Epidemiology of Diabetes Complications cohort of childhood-onset type 1 diabetes.
METHODS: 115 normotensive type 1 diabetes individuals without known CAD, underwent a baseline exercise radionuclide ventriculography. Abnormal LVEF was defined as a resting ejection fraction <50% or a failure to increase ejection fraction with exercise by >5% (men) or a fall in ejection fraction with exercise (women). Cox proportional hazards models were used to predict the composite endpoint of MOD (first instance of major CAD, stroke, end-stage renal disease, blindness, amputation or diabetes-related death).
RESULTS: Mean baseline age was 28 and diabetes duration 19 years. In a mean follow-up of 19 years, 50 MOD events were identified. Allowing for established risk factors at baseline, abnormal LVEF (n = 22) independently predicted MOD incidence (HR = 2.12, 95% CI: 1.12-4.00, p = 0.022) but not major CAD (HR = 1.33, 95% CI: 0.53-3.33, p = 0.539).
CONCLUSIONS: An abnormal LVEF may identify diabetic cardiomyopathy and predict long term risk of MOD (but not CAD alone) in type 1 diabetes individuals, consistent with it reflecting microvascular disease.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Diabetic cardiomyopathy; Left ventricular ejection fraction; Major outcomes of diabetes; Microvascular complications; Type 1 diabetes

Mesh:

Year:  2017        PMID: 29366734      PMCID: PMC5820228          DOI: 10.1016/j.jdiacomp.2017.12.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  44 in total

1.  Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications.

Authors:  Gianluca Perseghin; Guido Lattuada; Francesco De Cobelli; Antonio Esposito; Tamara Canu; Francesca Ragogna; Paola Maffi; Paola Scifo; Antonio Secchi; Alessandro Del Maschio; Livio Luzi
Journal:  Int J Cardiol       Date:  2010-10-05       Impact factor: 4.164

2.  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

Authors: 
Journal:  Prev Med       Date:  1976-06       Impact factor: 4.018

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes.

Authors:  Stefano Bonapace; Andrea Rossi; Paola Lipari; Lorenzo Bertolini; Luciano Zenari; Laura Lanzoni; Guido Canali; Giulio Molon; Alessandro Mantovani; Giacomo Zoppini; Enzo Bonora; Enrico Barbieri; Giovanni Targher
Journal:  J Diabetes Complications       Date:  2015-05-16       Impact factor: 2.852

5.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T J Orchard; A M Secrest; R G Miller; T Costacou
Journal:  Diabetologia       Date:  2010-07-28       Impact factor: 10.122

Review 6.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 7.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

Review 8.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

Authors:  Ashish Aneja; W H Wilson Tang; Sameer Bansilal; Mario J Garcia; Michael E Farkouh
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

9.  Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study.

Authors:  Ewa Konduracka; Grazyna Cieslik; Danuta Galicka-Latala; Pawel Rostoff; Artur Pietrucha; Pawel Latacz; Grzegorz Gajos; Maciej T Malecki; Jadwiga Nessler
Journal:  Acta Diabetol       Date:  2013-01-30       Impact factor: 4.280

10.  Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study.

Authors:  Leif Brunvand; Drude Fugelseth; Knut Håkon Stensaeth; Knut Dahl-Jørgensen; Hanna Dis Margeirsdottir
Journal:  BMC Cardiovasc Disord       Date:  2016-05-25       Impact factor: 2.298

View more
  1 in total

1.  Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.

Authors:  Rachel G Miller; Trevor J Orchard; Tina Costacou
Journal:  Diabetes Res Clin Pract       Date:  2020-04-08       Impact factor: 5.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.